Skip to main content

Table 1 Patient characteristics of the study population

From: Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

Characteristic Median Percentage/range
Age (years) 62.2 36–82
Initial CA-125 level (U/mL) 920 41–24440
CA-125 decreasing kinetics 2.2 0.9–28.6
Tumor sites a
  < = 3 38 23.7%
  > 3 122 76.3%
Preoperative ascites
  < 500 ml 88 55.0%
  > =500 ml 72 45.0%
Surgical residual
 No macroscopic focus 129 80.6%
 1–2 cm 6 3.8%
  > 2 cm 23 14.4%
 Unknown 2 1.3%
FIGO stage b
 IIIc 133 83.1%
 IV 27 16.9%
  1. Tumor sites a abdomen is divided into four quadrants according to the belly button
  2. FIGO b the International Federation of Gynecology and Obstetrics